WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
Soft tissue sarcomas (STS) are a very heterogeneous group of rare tumors, comprising more than 50 different histological subtypes that originate from mesenchymal tissue. Despite their heterogeneity, chemotherapy based on doxorubicin (DXR) has been in use for forty years now and remains the standard...
Guardado en:
Autores principales: | Esther Martinez-Font, Marina Pérez-Capó, Oliver Vögler, Javier Martín-Broto, Regina Alemany, Antònia Obrador-Hevia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a45dc9a8d91e4650bb49e2236ccc4c4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
por: A. S. Kulakova, et al.
Publicado: (2021) -
FERMT3 mediates cigarette smoke-induced epithelial–mesenchymal transition through Wnt/β-catenin signaling
por: Xiaoshan Su, et al.
Publicado: (2021) -
CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway
por: Li-Na Gao, et al.
Publicado: (2021) -
Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox<sup>®</sup>
por: Ramona D’Amico, et al.
Publicado: (2021) -
Expression of Wnt and β-Catenin in Mouse Tooth Germs and Chick Facial Primordia: A Comparison
por: Louryan,S., et al.
Publicado: (2018)